TNF antagonist better in treatment of early rheumatoid arthritis
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trialLancet. 2009 Aug 8;374(9688):459-66.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE